Key result
Intermuscular S-ICD implantation succeeds with normal defibrillation thresholds in 1 patient with pectus excavatum.
Case Report (n=1)
No
Demonstrates the feasibility and safety of intermuscular implantation of a subcutaneous ICD in a patient with pectus excavatum.
Offers alternative in pectus excavatum; extends case evidence but should not yet change practice.
The entirely subcutaneous implantable cardioverter-defibrillator (ICD) system was developed to provide a life-saving defibrillation therapy that does not affect the heart and vasculature. The subcutaneous ICD is preferred over the transvenous ICD for patients with a history of recurrent infection presenting major life-threatening rhythms. In this case report, we describe the first successful intermuscular implantation of a completely subcutaneous ICD in a Japanese patient with pectus excavatum. There were no associated complications with the device implantation or lead positioning. Further, the defibrillation threshold testing did not pose any problem with the abnormal anatomy of the patient.
No takes yet. Share an insight, caveat, or question.
Kondo et al. (2016) conducted a case report in Pectus excavatum requiring ICD (n=1). Intermuscular implantation of subcutaneous implantable cardioverter-defibrillator (ICD) was evaluated on Procedural success, complications, and defibrillation threshold testing. Intermuscular implantation of a subcutaneous ICD was successful in 1 patient with pectus excavatum, with 0 complications and normal defibrillation threshold testing.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: